MOTION Trial Will Pit Boniva Against Fosamax

Drug Industry Daily
KEYWORDS FDA / Trial
A A

Roche and GlaxoSmithKline (GSK) are raising the stakes in the osteoporosis drug market, announcing Sept. 26 they will launch a clinical trial pitting their new monthly osteoporosis treatment Boniva against Pfizer’s Fosamax, the current market leader.

To View This Article:

Login

Subscribe To Drug Industry Daily